Cubist Systematic Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.2M Buy
7,800
+1,700
+28% +$493K 0.01% 1509
2025
Q2
$1.7M Buy
+6,100
New +$1.73M 0.01% 1644
2025
Q1
Sell
-7,700
Closed -$2.01M 2820
2024
Q4
$2.01M Sell
7,700
-1,500
-16% -$445K 0.01% 1346
2024
Q3
$2.96M Buy
9,200
+3,800
+70% +$1.24M 0.02% 1188
2024
Q2
$1.69M Buy
5,400
+900
+20% +$264K 0.01% 1442
2024
Q1
$1.28M Sell
4,500
-12,100
-73% -$3.54M 0.01% 1970
2023
Q4
$4.78M Sell
16,600
-9,000
-35% -$2.45M 0.03% 897
2023
Q3
$6.88M Sell
25,600
-11,900
-32% -$2.97M 0.05% 574
2023
Q2
$8.33M Buy
37,500
+12,000
+47% +$2.78M 0.06% 530
2023
Q1
$6.16M Buy
25,500
+5,700
+29% +$1.4M 0.04% 781
2022
Q4
$5.2M Sell
19,800
-11,900
-38% -$3.19M 0.03% 980
2022
Q3
$7.14M Buy
31,700
+11,600
+58% +$2.81M 0.04% 744
2022
Q2
$4.89M Buy
+20,100
New +$4.93M 0.03% 1006

Other funds holding AMGN

Cubist Systematic Strategies's AMGN Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Amgen (AMGN) in Q1 2024, closing a stake of 32,454 shares — an estimated $9.5M sold.

Cubist Systematic Strategies first reported a position in AMGN in Q2 2014 and held it in 37 quarters. The position peaked at $47.7M in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 32,454 Amgen shares in Q1 2024, an estimated $9.5M.
  • Cubist Systematic Strategies first reported a position in Amgen in Q2 2014 and held it in 37 quarters.
  • Cubist Systematic Strategies's Amgen position peaked at $47.7M in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.